EC Healthcare Schedules Board Meeting to Review Interim Results
EC Healthcare has announced a board meeting on 28 November 2025 to review interim results for the six months ending 30 September 2025 and discuss potential interim dividends. This meeting will provide insights into the company's financial health and potential returns for stakeholders. The latest analyst rating for EC Healthcare stock is a Hold with a HK$0.50 price target. The company operates in the healthcare industry and is listed on the Hong Kong Stock Exchange.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
EC Healthcare ( (HK:2138) ) has issued an update.
EC Healthcare has announced that its board of directors will meet on 28 November 2025 to consider and approve the interim results for the six months ending 30 September 2025. The board will also discuss the potential payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial health and potential returns for stakeholders.
The most recent analyst rating on (HK:2138) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on EC Healthcare stock, see the HK:2138 Stock Forecast page.
More about EC Healthcare
EC Healthcare is a company incorporated in the Cayman Islands, operating in the healthcare industry. It is listed on the Hong Kong Stock Exchange and provides a range of healthcare services.
Average Trading Volume: 1,445,399
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$770.4M
